Corneal confocal microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy

Mitra Tavakoli, Cristian Quattrini, Caroline Abbott, Panagiotis Kallinikos, Andrew Marshall, Joanne Finnigan, Philip Morgan, Nathan Efron, Andrew J M Boulton, Rayaz Malik

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

OBJECTIVE - The accurate quantification of human diabetic neuropathy is important to define at-risk patients, anticipate deterioration, and assess new therapies. RESEARCH DESIGN AND METHODS - A total of 101 diabetic patients and 17 age-matched control subjects underwent neurological evaluation, neurophysiology tests, quantitative sensory testing, and evaluation of corneal sensation and corneal nerve morphology using corneal confocal microscopy (CCM). RESULTS - Corneal sensation decreased significantly (P = 0.0001) with increasing neuropathic severity and correlated with the neuropathy disability score (NDS) (r = 0.441, P < 0.0001). Corneal nerve fiber density (NFD) (P < 0.0001), nerve fiber length (NFL), (P < 0.0001), and nerve branch density (NBD) (P < 0.0001) decreased significantly with increasing neuropathic severity and correlated with NDS (NFD r = -0.475, P < 0.0001; NBD r = -0.511, P < 0.0001; and NFL r = -0.581, P < 0.0001). NBD and NFL demonstrated a significant and progressive reduction with worsening heat pain thresholds (P = 0.01). Receiver operating characteristic curve analysis for the diagnosis of neuropathy (NDS >3) defined an NFD of <27.8/mm 2 with a sensitivity of 0.82 (95% CI 0.68-0.92) and specificity of 0.52 (0.40-0.64) and for detecting patients at risk of foot ulceration (NDS >6) defined a NFD cutoff of <20.8/mm 2 with a sensitivity of 0.71 (0.42-0.92) and specificity of 0.64 (0.54-0.74). CONCLUSIONS - CCM is a noninvasive clinical technique that may be used to detect early nerve damage and stratify diabetic patients with increasing neuropathic severity.

Original languageEnglish
Pages (from-to)1792-1797
Number of pages6
JournalDiabetes Care
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 2010
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Confocal Microscopy
Neurophysiology
Research Design
N-formyl-13-dihydrocarminomycin
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialised Nursing

Cite this

Corneal confocal microscopy : A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. / Tavakoli, Mitra; Quattrini, Cristian; Abbott, Caroline; Kallinikos, Panagiotis; Marshall, Andrew; Finnigan, Joanne; Morgan, Philip; Efron, Nathan; Boulton, Andrew J M; Malik, Rayaz.

In: Diabetes Care, Vol. 33, No. 8, 08.2010, p. 1792-1797.

Research output: Contribution to journalArticle

Tavakoli, M, Quattrini, C, Abbott, C, Kallinikos, P, Marshall, A, Finnigan, J, Morgan, P, Efron, N, Boulton, AJM & Malik, R 2010, 'Corneal confocal microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy', Diabetes Care, vol. 33, no. 8, pp. 1792-1797. https://doi.org/10.2337/dc10-0253
Tavakoli, Mitra ; Quattrini, Cristian ; Abbott, Caroline ; Kallinikos, Panagiotis ; Marshall, Andrew ; Finnigan, Joanne ; Morgan, Philip ; Efron, Nathan ; Boulton, Andrew J M ; Malik, Rayaz. / Corneal confocal microscopy : A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. In: Diabetes Care. 2010 ; Vol. 33, No. 8. pp. 1792-1797.
@article{53d14258dfa441189e8b482b9001c3b2,
title = "Corneal confocal microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy",
abstract = "OBJECTIVE - The accurate quantification of human diabetic neuropathy is important to define at-risk patients, anticipate deterioration, and assess new therapies. RESEARCH DESIGN AND METHODS - A total of 101 diabetic patients and 17 age-matched control subjects underwent neurological evaluation, neurophysiology tests, quantitative sensory testing, and evaluation of corneal sensation and corneal nerve morphology using corneal confocal microscopy (CCM). RESULTS - Corneal sensation decreased significantly (P = 0.0001) with increasing neuropathic severity and correlated with the neuropathy disability score (NDS) (r = 0.441, P < 0.0001). Corneal nerve fiber density (NFD) (P < 0.0001), nerve fiber length (NFL), (P < 0.0001), and nerve branch density (NBD) (P < 0.0001) decreased significantly with increasing neuropathic severity and correlated with NDS (NFD r = -0.475, P < 0.0001; NBD r = -0.511, P < 0.0001; and NFL r = -0.581, P < 0.0001). NBD and NFL demonstrated a significant and progressive reduction with worsening heat pain thresholds (P = 0.01). Receiver operating characteristic curve analysis for the diagnosis of neuropathy (NDS >3) defined an NFD of <27.8/mm 2 with a sensitivity of 0.82 (95{\%} CI 0.68-0.92) and specificity of 0.52 (0.40-0.64) and for detecting patients at risk of foot ulceration (NDS >6) defined a NFD cutoff of <20.8/mm 2 with a sensitivity of 0.71 (0.42-0.92) and specificity of 0.64 (0.54-0.74). CONCLUSIONS - CCM is a noninvasive clinical technique that may be used to detect early nerve damage and stratify diabetic patients with increasing neuropathic severity.",
author = "Mitra Tavakoli and Cristian Quattrini and Caroline Abbott and Panagiotis Kallinikos and Andrew Marshall and Joanne Finnigan and Philip Morgan and Nathan Efron and Boulton, {Andrew J M} and Rayaz Malik",
year = "2010",
month = "8",
doi = "10.2337/dc10-0253",
language = "English",
volume = "33",
pages = "1792--1797",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Corneal confocal microscopy

T2 - A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy

AU - Tavakoli, Mitra

AU - Quattrini, Cristian

AU - Abbott, Caroline

AU - Kallinikos, Panagiotis

AU - Marshall, Andrew

AU - Finnigan, Joanne

AU - Morgan, Philip

AU - Efron, Nathan

AU - Boulton, Andrew J M

AU - Malik, Rayaz

PY - 2010/8

Y1 - 2010/8

N2 - OBJECTIVE - The accurate quantification of human diabetic neuropathy is important to define at-risk patients, anticipate deterioration, and assess new therapies. RESEARCH DESIGN AND METHODS - A total of 101 diabetic patients and 17 age-matched control subjects underwent neurological evaluation, neurophysiology tests, quantitative sensory testing, and evaluation of corneal sensation and corneal nerve morphology using corneal confocal microscopy (CCM). RESULTS - Corneal sensation decreased significantly (P = 0.0001) with increasing neuropathic severity and correlated with the neuropathy disability score (NDS) (r = 0.441, P < 0.0001). Corneal nerve fiber density (NFD) (P < 0.0001), nerve fiber length (NFL), (P < 0.0001), and nerve branch density (NBD) (P < 0.0001) decreased significantly with increasing neuropathic severity and correlated with NDS (NFD r = -0.475, P < 0.0001; NBD r = -0.511, P < 0.0001; and NFL r = -0.581, P < 0.0001). NBD and NFL demonstrated a significant and progressive reduction with worsening heat pain thresholds (P = 0.01). Receiver operating characteristic curve analysis for the diagnosis of neuropathy (NDS >3) defined an NFD of <27.8/mm 2 with a sensitivity of 0.82 (95% CI 0.68-0.92) and specificity of 0.52 (0.40-0.64) and for detecting patients at risk of foot ulceration (NDS >6) defined a NFD cutoff of <20.8/mm 2 with a sensitivity of 0.71 (0.42-0.92) and specificity of 0.64 (0.54-0.74). CONCLUSIONS - CCM is a noninvasive clinical technique that may be used to detect early nerve damage and stratify diabetic patients with increasing neuropathic severity.

AB - OBJECTIVE - The accurate quantification of human diabetic neuropathy is important to define at-risk patients, anticipate deterioration, and assess new therapies. RESEARCH DESIGN AND METHODS - A total of 101 diabetic patients and 17 age-matched control subjects underwent neurological evaluation, neurophysiology tests, quantitative sensory testing, and evaluation of corneal sensation and corneal nerve morphology using corneal confocal microscopy (CCM). RESULTS - Corneal sensation decreased significantly (P = 0.0001) with increasing neuropathic severity and correlated with the neuropathy disability score (NDS) (r = 0.441, P < 0.0001). Corneal nerve fiber density (NFD) (P < 0.0001), nerve fiber length (NFL), (P < 0.0001), and nerve branch density (NBD) (P < 0.0001) decreased significantly with increasing neuropathic severity and correlated with NDS (NFD r = -0.475, P < 0.0001; NBD r = -0.511, P < 0.0001; and NFL r = -0.581, P < 0.0001). NBD and NFL demonstrated a significant and progressive reduction with worsening heat pain thresholds (P = 0.01). Receiver operating characteristic curve analysis for the diagnosis of neuropathy (NDS >3) defined an NFD of <27.8/mm 2 with a sensitivity of 0.82 (95% CI 0.68-0.92) and specificity of 0.52 (0.40-0.64) and for detecting patients at risk of foot ulceration (NDS >6) defined a NFD cutoff of <20.8/mm 2 with a sensitivity of 0.71 (0.42-0.92) and specificity of 0.64 (0.54-0.74). CONCLUSIONS - CCM is a noninvasive clinical technique that may be used to detect early nerve damage and stratify diabetic patients with increasing neuropathic severity.

UR - http://www.scopus.com/inward/record.url?scp=77957558519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957558519&partnerID=8YFLogxK

U2 - 10.2337/dc10-0253

DO - 10.2337/dc10-0253

M3 - Article

C2 - 20435796

AN - SCOPUS:77957558519

VL - 33

SP - 1792

EP - 1797

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 8

ER -